Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer’s and even restores memories in mice, they report Jan. 2 in the journal Cell Reports.
The binding of amyloid beta peptides to prion proteins triggers a cascade of devasting events in the progression of Alzheimer’s — accumulation of plaques, a destructive immune system response, and damage to synapses.
“We wanted to find molecules that might have a therapeutic effect on this network,” said senior author Stephen Strittmatter, the Vincent Coates Professor of Neurology, professor of neuroscience, and director of the Yale Alzheimer Disease Research Center.
Strittmatter and research scientist Erik Gunther screened tens of thousands of compounds looking for molecules that might interfere with the damaging prion protein interaction with amyloid beta. They found that an old antibiotic looked like a promising candidate but was only active after decomposing to form a polymer. Related small polymers retained the benefit and also managed to pass through the blood-brain barrier.
They then dissolved the optimized polymeric compound and fed it to mice engineered to have a condition that mimics Alzheimer’s. They found that synapses in the brains were repaired and mice recovered lost memory.
A collaborating team at Dartmouth University reported a positive response when they delivered the same cocktail to cells modeled to have Creutzfeldt-Jakob Disease, a devasting neurological condition caused by infection with misfolded prion protein.
The next step is to verify the compounds aren’t toxic in preparation for translation to clinical trials for Alzheimer’s disease.
The Latest on: Designer molecules
via Google News
The Latest on: Designer molecules
- More targeted, less toxic: The golden future of cancer treatmenton September 6, 2019 at 12:11 am
The molecules were also more targeted and selective ... of chronic inflammatory conditions like arthritis. Molecular design pioneers Part of RMIT's Centre for Advanced Materials and Industrial ...
- Using synthetic biology to design new kinds of life—and novel drugs to treat diseaseson September 5, 2019 at 5:32 am
[Jason] Chin’s work paves the way for an engineered ribosome that could assemble a much larger repertoire of amino acids into molecules that, with tens of thousands of amino acids and millions ...
- Open database design lists pollutants in the Rhineon September 4, 2019 at 2:09 am
Rivers can contain a vast range of small molecules, including pharmaceuticals, industrial chemicals and agrochemicals. Analysis is typically carried out by some form of LC-MS, but manual examination ...
- Novel Molecules Designed by Artificial Intelligence in 21 Days Are Validated in Miceon September 3, 2019 at 11:24 am
The traditional drug discovery starts with the testing of thousands of small molecules in order to get to just a few ... and likely to be applicable to many other problems in drug-design," said Dr.
- AI helped design a promising drug in flat 21 dayson September 3, 2019 at 5:46 am
The creation of the new molecules marks the industry's first ... and likely to be applicable to many other problems in drug-design," said Dr Michael Levitt, professor of structural biology ...
- This Startup Used AI To Design A Drug In 21 Dayson September 2, 2019 at 9:44 am
It took about 21 days for the AI system to design molecules, and the total time for design, synthesis and validation was about 46 days. Although none of the drugs designed by GENTRL would appear to be ...
- GSK and Unilever Among Early Adopters of BioLeap’s Technology for Creating New Moleculeson August 22, 2019 at 5:00 pm
“We need to figure out those targets and then use a pharmaceutical approach to design molecules that work specifically against them.” BioLeap was founded in 2004 with a new approach to “computational ...
- Materials that can revolutionize how light is harnessed for solar energyon August 19, 2019 at 9:10 am
In a study published this month in Nature Chemistry, the team details the design of organic molecules that are capable of generating two excitons per photon of light, a process called singlet fission.
- Design of Organic Molecules with Large Two-Photon Absorption Cross Sectionson June 26, 2019 at 7:01 am
M. Albota, S. E. Hess, W. W. Webb, C. Xu, School of Applied Physics and Engineering, and Developmental Resource for Biophysical Imaging Opto-Electronics, Cornell University, Ithaca, NY 14853, USA. D.
- Biologists design new molecules to help stall lung canceron April 22, 2019 at 5:27 am
University of Texas at Dallas scientists have demonstrated that the growth rate of the majority of lung cancer cells relates directly to the availability of a crucial oxygen-metabolizing molecule. In ...
via Bing News